OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2022
(3)
2023
(2)
2021
(2)
2024
(1)
2020
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Factors associated with enrolment in clinical trials among women with early-stage breast cancer.
Not available
S-EPMC9271499
|
biostudies-literature
Cite
Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuation.
Not available
S-EPMC10483331
|
biostudies-literature
Cite
Long-term patient reported outcomes and hematologic toxicity among patients who received Granulocyte-Colony Stimulating Factors during chemotherapy for early breast cancer.
Not available
S-EPMC7970125
|
biostudies-literature
Cite
Mass Training In Situ During COVID-19 Pandemic: Enhancing Efficiency and Minimizing Sick Leaves.
Not available
S-EPMC8808751
|
biostudies-literature
Cite
Contraceptive Use in Premenopausal Women With Early Breast Cancer.
Not available
S-EPMC9508662
|
biostudies-literature
Cite
Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial.
Not available
S-EPMC10460760
|
biostudies-literature
Cite
Economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): study protocol.
Not available
S-EPMC7322334
|
biostudies-literature
Cite
Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial.
Not available
S-EPMC8456390
|
biostudies-literature
Cite
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Not available
S-EPMC10867612
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets